KATJA LOHMANN

 

PERSONAL INFORMATION

Position/Title: Vice Head (Institute of Neurogenetics), W2 Professor

Address University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany

Tel: +49-451-31018209; Fax:+49-451-31018204

@: katja.lohmann@neuro.uni-luebeck.de; www.neurogenetics-luebeck.de

 

EDUCATION/POSITIONS

1995-1997 Studies of Biology (B.Sc. equivalent) at the Technical University Dresden

1997-2000 Studies of Biology (M.Sc. equivalent) at the Martin Luther University Halle-Wittenberg

2000-2003 PhD studies at the University of Lübeck, Institute of Human Genetics and Department of Neurology

2001-2002 PhD student at Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA (Prof. X.O. Breakefield)

2003-2009 Postdoctoral researcher at the Institute of Human Genetics and the Department of Neurology at the University of Lübeck

2005 Postdoctoral fellow at the Oregon Health and Science University, Portland, OR, USA (Prof. P.L. Kramer)

2010 Habilitation (Assistant Professor equivalent) at the Medical faculty of the University of Lübeck for Human Genetics

2009-2013 Research group leader at the Department of Neurology at the University of Lübeck

2013-present Research group leader and Vice Director of the Institute of Neurogenetics at the University of Lübeck

2015-2017 Professor (APL)

Since 2017 W2 Professor (Molecular Genetics of Rare Diseases)

 

ACADEMIC ACTIVITIES

2000-present Member of the German Society of Human Genetics, the European Society of Human Genetics, and the American Society of Human Genetics; Member of the International Parkinson and Movement Disorder Society

2004-present Ad hoc reviewer for >15 journals (e.g. American Journal of Human Genetics, Annals of Neurology, Brain, Movement Disorders, Molecular Psychiatry)

2013-present Reviewer for several funding agencies (e.g. DFG, BMBF, French National Research Agency, Research Foundation Flanders)

2017-present Member of the expert panel of the German Academy for Rare Neurological Diseases (DASNE)

2018-present Editorial board member Movement Disorders and DGNeurologie

2019-present Board member Dystract e.V.

2019-present Member of the Data Interpretation Task Force (DITF) of the European Reference Network on Rare Neurological diseases (ERN-RND)

2019-present Member of the Awards Committee of the International Parkinson and Movement Disorder Society

 

AWARDS

2004 Heinrich Dräger Award

2008 Stipend of the Novartis Foundation

2011 Renate Maass Award for Brain Research

2013 David Marsden Award for Dystonia Research (Dystonia Europe)

 

SELECTED PUBLICATIONS

From 195 original publications; total citations: 7,956; h-index: 52

  1. Müller B, Hedrich K (equally contributing first author), Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C. Evidence for paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002;71:1303-1311. [IF: 10.6]
  2. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007;6:652-662. [IF: 10.2]
  3. Djarmati A, Schneider SA, Lohmann K, Winkler S, Pawlack H, Hagenah J, Brüggemann N, Zittel S, Fuchs T, Raković A, Schmidt A, Jabusch HC, Wilcox R, Kostić VS, Siebner H, Altenmüller E, Münchau A, Ozelius LJ, Klein C. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009;8:447-452. [IF: 18.1]
  4. Kaiser FJ, Osmanoric A, Rakovic A, Erogullari A, Uflacker N, Braunholz D, Lohnau T, Orolicki S, Albrecht M, Gillessen-Kaesbach G, Klein C, Lohmann K. The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Ann Neurol 2010;68:554-559. [IF: 10.7]
  5. Lohmann K, Wilcox R, Winkler S, Ramirez A, Rakovic A, Park J, Arns B, Lohnau T, Groen J, Kasten M, Brüggemann N, Hagenah J, Schmidt A, Kaiser FJ, Kumar KR, Zschiedrich K, Alvarez-Fischer D, Altenmüller E, Ferbert A, Lang A, Münchau A, Kostic V, Simonyan M, Agzarian M, Ozelius LJ, Langeveld APM, Sue CM, Tijssen M, Klein C: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol 2013;73: 537–545. [IF: 11.9]
  6. Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, Lemos RR, Ordoñez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, Lohmann K, Dobričić V, Carracedo A, Petrović I, Miyasaki JM, Abakumova I, Mäe MA, Raschperger E, Zatz M, Zschiedrich K, Klepper J, Spiteri E, Prieto JM, Navas I, Preuss M, Dering C, Janković M, Paucar M, Svenningsson P, Saliminejad K, Khorshid HR, Novaković I, Aguzzi A, Boss A, Le Ber I, Defer G, Hannequin D, Kostić VS, Campion D, Geschwind DH, Coppola G, Betsholtz C, Klein C, Oliveira JR. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 2013;45:1077-1082. [IF: 29.6]
  7. Lohmann K, Redin C, Tönnies H, Bressman SB, Martin-Subero JI, Wiegers K, Hinrichs F, Hellenbroich Y, Rakovic A, Raymond D, Ozelius LJ, Schwinger E, Siebert R, Talkowski ME, Saunders-Pullman R, Klein C. Complex and dynamic chromosomal rearrangements in a family with seemingly non-Mendelian inheritance of dopa-responsive dystonia. JAMA Neurol 2017;74:806-812. [IF: 11.5]
  8. Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, König IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C. Genotype-phenotype relations for the Parkinson’s Disease genes Parkin, PINK1, DJ1: MDSGene Systematic Review. Mov Disord 2018;33:730-741. [IF: 8.1]
  9. Seong E, Insolera R, Dulovic M, Kamsteeg EJ, Trinh J, Brüggemann N, Sandford E, Li S, Ozel AB, Li JZ, Jewett T, Kievit AJA, Münchau A, Shakkottai V, Klein C, Collins C, Lohmann K (co-corresponding author), van de Warrenburg BP, Burmeister M. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. Ann Neurol 2018;83:1075-1088. [IF: 9.5]
  10. Dulovic-Mahlow M, Trinh J, Kandaswamy KK, Braathen GJ, Di Donato N, Rahikkala E, Beblo S, Werber M, Krajka V, Busk OL, Baumann H, Abbas Al-Sannaa, Hinrichs F, Navot N, Al Balwi MA, Oprea G, Holla OL, Weiss MER, Jamra RA, Kahlert AK, Kishore S, Tveten K, Vos M, Rolfs A, Lohmann K. De-novo variants in TAOK1 cause neurodevelopmental disorders. Am J Hum Genet 2019;105:213-220. [IF: 9.9]